Detection of Label-Free Drugs within Brain Tissue Using Orbitrap Secondary Ion Mass Spectrometry as a Complement to Neuro-Oncological Drug Delivery
Historically, pre-clinical neuro-oncological drug delivery studies have exhaustively relied upon overall animal survival as an exclusive measure of efficacy. However, with no adopted methodology to both image and quantitate brain parenchyma penetration of label-free drugs, an absence of efficacy typ...
Main Authors: | Phoebe McCrorie, Jonathan Rowlinson, David J. Scurr, Maria Marlow, Ruman Rahman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/3/571 |
Similar Items
-
Spatially Resolved Molecular Analysis of Host Response to Medical Device Implantation Using the 3D OrbiSIMS Highlights a Critical Role for Lipids
by: Waraporn Suvannapruk, et al.
Published: (2024-04-01) -
OrbiFragsNets. A tool for automatic annotation of orbitrap MS2 spectra using networks grade as selection criteria
by: Edwin Chingate, et al.
Published: (2023-12-01) -
My Experience with Orbis International and the Flying Eye Hospital in Ethiopia
by: Jibat G. Soboka, et al.
Published: (2021-01-01) -
Forma Orbis. Il campo di fondazione dell'architettura
by: Riccardo Palma
Published: (2017-12-01) -
Orbis Tertius
by: Sebastián Hernaiz
Published: (2015-09-01)